In confirmation of the involvement of GSDMB in MS, it was shown that the reduction of GSDMB in memory CD4+ T cells led to an increase in cytokine production, including TNF, IL-13, and IL-16 [76]. This evidence concerns the gene TNF and myeloid sarcoma.